Table 3.
Summary of comorbidity history in patients with coronavirus disease 2019 (COVID-19)
| Comorbidity | Huang et al.[1]. (n = 41) | Chen et al.[17]. (n = 99) | Wang et al.[13]. (n = 138) | Guan et al.[27]. (n = 1099) | Richardson et al.[47]. (n = 5700) |
|---|---|---|---|---|---|
| Cardiovascular disease | 6 (14.6) | 40 (40.4) | 20 (14.5) | 42(3.9) | 996 (16.9) |
| Hypertension | 6 (14.6) | NR | 43 (31.2) | 165 (15) | 3026 (56.6) |
| Diabetes | 8 (19.5) | 12 (12.1) | 14 (10.1) | 81 (7.4) | 1808 (33.8) |
| Respiratory disease | 1 (2.4) | 1 (1.0) | 4 (2.9) | 12 (1.1) | 920 (16.1) |
| Malignancy | 1 (2.4) | 1 (1.0) | 10 (7.2) | 10 (0.9) | 320 (6) |
| Chronic kidney disease | NR | NR | 4 (2.9) | 8 (0.7) | 454 (7.9) |
| Chronic liver disease | 1 (2.4) | NR | 4 (2.9) | 23 (21) | 30 (0.5) |
All data are expressed as n (%)
NR not reported